The Biotech Growth Trust Plc - Net Asset Value(s)
PR Newswire
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 30 April 2021 was 1426.98p (ex income) 1426.59p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
FNRD-2.621.0
Wie bewerten Sie die aktuell angezeigte Seite?sehr gut123456schlechtProblem melden
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
The Biotech Growth Trust Plc - Net Asset Value(s) finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
The Biotech Growth Trust Plc - Monthly Fact Sheet as at 31 March 2021 PR Newswire London, April 22 The Biotech Growth Trust PLC 22 April 2021 Monthly Fact Sheet
The Biotech Growth Trust Plc - Issue of Equity
PR Newswire
22 April 2021
Allotment of Ordinary Shares
THE BIOTECH GROWTH TRUST PLC (the Company ) announces the allotment of 30,000 Ordinary shares of 25p each fully paid from its block listing authority.
These shares were issued today at a price of 1425.50 pence per Ordinary share, which equates to a premium to the estimated ex income net asset value per Ordinary share at the time of transaction of 1%. The ex income net asset value per Ordinary share at the close of business on 21 April 2021 was 1407.09 pence.
Following this issue, the Company has the ability to issue a further 3,600,634 Ordinary shares its block listing facility.
The Biotech Growth Trust Plc - Net Asset Value(s)
PR Newswire
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 21 April 2021 was 1407.09p (ex income) 1406.73p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
FNRD-2.621.0
Wie bewerten Sie die aktuell angezeigte Seite?sehr gut123456schlechtProblem melden
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,